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Abstract
Lassa fever is a disease that has been reported from sites across West Africa; it is caused by an arenavirus that is hosted by
the rodent M. natalensis. Although it is confined to West Africa, and has been documented in detail in some well-studied
areas, the details of the distribution of risk of Lassa virus infection remain poorly known at the level of the broader region. In
this paper, we explored the effects of certainty of diagnosis, oversampling in well-studied region, and error balance on
results of mapping exercises. Each of the three factors assessed in this study had clear and consistent influences on model
results, overestimating risk in southern, humid zones in West Africa, and underestimating risk in drier and more northern
areas. The final, adjusted risk map indicates broad risk areas across much of West Africa. Although risk maps are increasingly
easy to develop from disease occurrence data and raster data sets summarizing aspects of environments and landscapes,
this process is highly sensitive to issues of data quality, sampling design, and design of analysis, with macrogeographic
implications of each of these issues and the potential for misrepresenting real patterns of risk.
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Introduction
Lassa fever (LF) is a zoonotic disease caused by Lassa virus
(LASV), a member of the Arenaviridae family [1]. Clinical
manifestations range from mild febrile illness to severe vascular
leakage, hemorrhage, shock, and death. Introduction of LASV
into humans occurs through direct or indirect contact with excreta
of the natural reservoir, the rodent Mastomys natalensis, although
precise modes of transmission are not well characterized [2].
Human-to-human transmission of LASV through contact with
blood and other bodily fluids has been documented, particularly in
clinical settings [3].
Although decades of experience and numerous epidemiological
studies make it clear that LF is a phenomenon of the West African
sub-region [1,4], the details of the spatial distribution of LASV and
LF remain unclear. Understanding the incidence and distribution
of LF has been hampered by lack of easily-available diagnostics
and limited public health surveillance infrastructure in the region
[5]. LF is best characterized in areas with research programs
focusing on the disease, particularly central and southern Nigeria
and eastern Sierra Leone [5,6]. Beyond these focal areas of
surveillance activity, estimates of LASV distribution are coarse,
providing little basis for inference into intervening areas of West
Africa. As a result, the reported incidence of LF shows significant
spatial clustering owing to reporting bias, a common phenomenon
among neglected and emerging diseases.
In a recent publication, Fichet-Calvet and Rogers [7] provided
‘‘risk maps of Lassa fever in West Africa,’’ assembling a data set of
111 occurrences of LASV infection and LF from published
seroprevalence studies and clinical case reports (Figure 1). Rodent
occurrence data were also compiled in the study, but were
excluded from analyses. The resultant maps have been cited and
republished frequently as definitive distribution risk maps for LF
[8]. The maps, however, developed using ecological niche
modeling approaches, show several characteristics of concern
(Figure 2) [9]: high-risk areas are broadly disjunct at the western
and eastern extremes of West Africa, without apparent coinci-
dence with known biogeographic or environmental breaks, and
(most worrisome) high-risk areas coincide closely with areas of
most intense sampling (i.e., near research centers). This result
suggests either that LF occurrence has been sampled thoroughly in
the only areas where it is most prevalent (i.e., its distribution is
well-characterized by existing sampling), or that models were
overfit to input data, producing risk maps with little generality or
predictive power [10], offering a falsely clear geographic picture of
risk. Overfit models are those that replicate well the input data,
identifying areas that have already been sampled, but that have
little generality that might permit genuine prediction and
anticipation of risk in areas where sampling has not occurred.
Such models often perform poorly when challenged to predict
independent sets of data, as might be produced in the present case
via intensive on-ground studies in, for example, Benin or Togo.
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While the patterns presented by Fichet-Calvet and Rogers may
indeed be correct, the concerns that their results engender demand
more in-depth examination. Here, we present a series of further
analyses of their data, re-examining them in terms of possible
sources of bias in risk-map development (see parallel example in
[11]). In particular, we address three possible biases in the
occurrence data and analytical methods related to (1) quality
control regarding definition of occurrence (i.e., high versus low-
confidence documentation of LASV infection/LF cases), (2)
controlling for sampling bias (i.e., accounting for the fact that
some areas have been subject to intensive surveillance for LF while
others have not), and (3) balancing potential for Type 1 and Type
2 errors appropriately in resulting models (i.e., taking into account
the fact that sites of known occurrences versus sites with no known
occurrence have different levels of confidence associated with
them). Throughout, our focus is on macrogeographic implications
of biases—if potential sources of confusion are random, their
effects might simply diffuse any signal that does exist in the data; if,
however, these sources of confusion have consistent environmental
correlates, then resulting risk maps will incorporate these biases
and macrogeographic implications will manifest. It should be
noted that the goal and result of our analysis is not necessarily to
present more accurate risk maps for LF per se, but rather to
illustrate pitfalls inherent in risk mapping when data are not
carefully considered and controlled.
Methods
Input data and study area
The occurrence data presented in Table 1 of Fichet-Calvet and
Rogers [7] were captured in spreadsheet format and organized for
further analysis. This data set was carefully referenced, which
permitted us to reexamine the quality of diagnostics for each
occurrence record as part of our analyses (see below). A few
Figure 1. Summary of occurrence data input in the ecological niche models. The dashed outline shows the limits of the area of analysis,
with circles indicating the data used by Fichet-Calvet and Rogers [7]. Gray circles indicate data that met quality control criteria levels 1 and 2 (see
Table 1). Black crosses indicate data after random subsampling (see Methods for rationale and details).
doi:10.1371/journal.pone.0100711.g001
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records were excluded from our analyses for lack of access to
documents referenced, leaving an initial 107 of Fichet-Calvet and
Rogers’ 111 data records as inputs to our analyses. We refer
henceforth refer to this data set as the ‘raw’ data.
The occurrence data were analyzed in the context of
environmental variation across West Africa, focusing on the
region relatively close to sites of known LF cases as a study region.
We examined occurrence data to identify the largest spatial
disjunction (,800 km), and used a buffer of this radius around
known occurrences as our study region (Figure 1). By choosing this
region as the area within which models are to be calibrated, we
assume it to have been accessible to LASV and its rodent host for
Figure 2. Mean predicted LF risk map from the Model 2 series developed by Fichet-Calvet and Rogers [7], with posterior probability
color scale from 0.0 (no risk) to 1.0 (highest risk) shown at inset. Gray areas are areas either lacking suitable imagery (because of cloud
contamination—coastal Nigeria and Cameroon) or that are so distant in environmental space that predictions were not possible. Used with
permission.
doi:10.1371/journal.pone.0100711.g002
Table 1. Quality control schema for diagnosis confidence for Lassa fever occurrence data from Fichet-Calvet and Rogers [7].
Validity rating Description
1 Virus isolate, PCR-positive, or ELISA-positive Mastomys natalensis
2 Virus isolate, PCR-positive, ELISA-positive, or plaque neutralization assay-positive human case of LF
3 Human case of LF supported by IFA or other laboratory test result
4 Serosurvey positive based on ELISA or plaque neutralization assay
5 Serosurvey positive based on IFA or other laboratory test
6 Human case of LF without supporting laboratory test
7 No evaluable information, no original data, or simply no data
Note that when multiple ratings applied to single points in space, we assigned the higher of the ratings, assuming that the greatest confidence is the most appropriate.
Abbreviations: ELISA, enzyme-linked immunosorbent assay; IFA, immunofluorescent assay; PCR, polymerase chain reaction.
doi:10.1371/journal.pone.0100711.t001
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potential colonization, and that some possibility exists of LF cases
in the region being detected, diagnosed, and reported. These
assumptions are not inconsequential; in effect, we have assumed
that within this region LF cases should be detected and reported,
and that sites and environments represented within this area that
do not hold case reports have a higher probability of lacking such
records because the conditions are not appropriate for LASV
transmission and maintenance [12].
Effects of quality control of diagnoses
The degree of confidence of a diagnosis of LASV infection/LF
is impacted by various factors; many or even most patients with LF
present with non-specific manifestations extremely difficult to
distinguish from many other common febrile illnesses in West
Africa, such as malaria or typhoid fever, making clinical diagnosis
difficult and laboratory diagnosis imperative [1,13,14]. Unfortu-
nately, no FDA-approved or widely validated laboratory tests exist
for LF, leaving only a few laboratories in the world capable of
reliably providing the diagnosis using various ‘‘in-house’’ assays.
Over the past few decades, only Sierra Leone, Nigeria, and
Guinea have been able to conduct laboratory tests for LF in-
country, and these often only intermittently and at times with
significant questions regarding quality control [4,13,15]. Further-
more, the various assays employed for LF have varying degrees of
sensitivity and specificity [1,4]. Tests that directly indicate
presence of LASV, such as cell culture, PCR, ELISA antigen
assays, and plaque neutralization assays [16,17], provide the most
definitive proof of infection, whereas antibody tests such as
immunofluorescence assays are generally less specific and thus
yield lower confidence in the diagnosis [18].
Uncertainty may also exist in the attribution of the geographic
location of LASV infection; infected persons may travel during the
incubation period (which may be up to three weeks), potentially
resulting in incorrect attribution of occurrence to site of illness
rather than infection [19]. It should be noted that M. natalensis
are ubiquitous in rural areas of West Africa, and that specific
infecting events are rarely recognized by persons with LF.
Infection is thought most often to occur via unwitting exposure
to M. natalensis excreta. Even when human-to-human transmis-
sion is involved, the specific contact or infecting event is usually
not recognized, again creating uncertainty regarding the geo-
graphic origin of the case.
To add a measure of quality control and to quantify the
confidence that should be accorded to each LF occurrence record,
we subset the Fichet-Calvet and Rogers data according to
reliability of the diagnostic method for each LF case record; an
expert (DGB) with long experience with LF, rated each record
according to a 7-point scale of certainty of diagnosis (Table 1) that
ranged from laboratory confirmed LASV-positive rodents (level 1,
highest confidence) to reports on human cases providing no
information about the basis of the diagnosis of LF (level 7, lowest
confidence). We accorded the highest confidence to rodent-
derived records owing to the lower probability of long-distance
movements of rodents that could result in attribution of LASV
occurrence in nonrepresentative areas. We excluded serosurveys
(i.e., studies in which healthy populations were tested for LASV-
reactive antibodies), since the timing, and thus geographic location
of the exposures of positive cases, could not be known. Serosurveys
are also fraught with uncertainty based on non-specificity of the
antibody assays, cross-reactive antibodies, and issues regarding
setting cut-offs for a positive result [1]. This quality control schema
was used to compare models based on all records (levels 1-7) with
models based on only levels 1 and 2, where confidence of the
presence of LASV infection/LF was highest.
Effects of uneven sampling across space
A second contrast explored was between the raw data set and a
subset in which we attempted to remove effects of spatial
concentrations of LF cases created by intensive sampling.
Concentrations of case reports may result from intensive
transmission and genuinely high incidence in the region, but
may also simply reflect areas of intensive study and sampling. To
this end, we identified the area of southeastern Sierra Leone,
southern Guinea, and northwestern Liberia as representing areas
of artificial over-reporting based on the intensive studies of LF that
have focused on these regions [4,13,20,21]. We identified 44 LF
cases (41% of the raw data set) coming from these intensively
studied regions and randomly removed 75% of them to produce a
reduced data set that included only 11 occurrences from these
areas. We then compared models based on the full raw and
reduced data sets. Finally, owing to interesting results that came
from this procedure (see below), we created 10 such randomized
subsamplings and examined variation among models based on
each, in effect testing to assure that the particular subsample
chosen in our initial reduction did not present spurious charac-
teristics not representative of the broader data set.
Effects of balance of error types
Finally, we examined effects of relative balancing of two types of
error in model calibration on model results. Any spatial prediction
manifests two types of error: omission error, in which known
presences of species (in this case, LASV-infected rodents or
humans) are left out of the prediction, and commission error, in
which areas not known to hold the species are predicted as suitable
[22]. Occurrence data are peculiar in that presence data are
relatively strong in their confidence—i.e., although some may
represent misdiagnoses or mistaken geographic references, the
great bulk of presence records accurately link the occurrence of a
given species with a particular site on landscapes. In contrast,
confidence in absence of occurrences is much lower [9]. In the
case of LF, absence of occurrence data may represent a genuine
lack of LASV transmission in a region. However, occurrence data
may be absent even when LASV is present in an area because (1)
no humans are present to get infected, (2) no contact occurs
between humans and the rodent reservoir to result in LASV
transmission, (3) humans are infected but no laboratory facility is
available to make a diagnosis, or (4) humans are diagnosed but
cases are not reported or case data is not available to researchers.
In some of the aforementioned circumstances, risk of LF may be
high despite the absence of recognized occurrences. As a
consequence, presence data and its associated omission error
should be accorded much higher weighting in model calibration
than absence data and its associated commission error [9].
To this end, we compared two approaches to model calibration;
in our first approach, we weighted omission and commission
errors equally to replicate the error balance used by Fichet-Calvet
and Rogers [7]. We combined multiple independent model
optimizations of the niche modeling algorithm GARP, which
depend on separate random subsamplings of available occurrence
data and on distinct random-walk model optimizations. Because
GARP optimizes a parameter that balances the two error
components equally [23], these consensus models reflect the equal
error weighting situation. In our second approach, we prioritized
minimization of omission error over minimization of commission
error by using the ‘‘best subsets’’ procedure of Anderson et al. [24]
that applies and prioritizes a filter based on omission error rates
before a filter based on commission error rates. Comparisons of
models created with these two approaches provide an effective
Revised Transmission Risk Maps for Lassa Fever
PLOS ONE | www.plosone.org 4 August 2014 | Volume 9 | Issue 8 | e100711
illustration of the effects of equal versus the more appropriate
omission-weighted error balance schemes in model calibration.
Model evaluation
Because data documenting LF occurrences across West Africa
are relatively few and are highly uneven in their distribution, our
evaluation of the effects of the three potential biases explored in
this paper was in large part qualitative and visual. We compared
views of model outputs before and after correcting for these
potential biases, as well as with the original figures presented by
Fichet-Calvet and Rogers (Figure 2). Niche models, such as those
that both we and Fichet-Calvet and Rogers used, are fitted in
environmental spaces [9] and thus manifest effects of biases only to
the degree that these factors create consistent, non-random
associations in environmental dimensions. If effects of a potential
bias are negligible or manifested on local scales only, then
differences before and after corrections for this bias would be
manifested as ‘salt and pepper’ or randomly dispersed and not as
consistent spatial differences.
For each of the three potential biases we considered, we created
difference maps contrasting both the magnitude and spatial
topology of the differences between the two treatments. Again, we
were seeking areas of consistent departure as opposed to salt-and-
pepper. Because initial model results showed intriguing patterns,
we sought to explore model results in the Sierra Leone-Liberia-
Guinea area in greater detail. We therefore carried out the 10
replicate subsamplings of available occurrence data described
above, which allowed us to assess whether our particular initial
subsampling yielded nonrepresentative results. Again, our assess-
ment was largely qualitative, as the results were quite clear in
showing consistent results from model to model.
As a local-scale evaluation of the import of our model
predictions, for this same region, we analyzed rodent-based
detections of LASV specifically. We used sources listed in Table 1
of Fichet-Calvet and Rogers [7] that were not included in their
analysis and additional data from rodent surveys in 13 Sierra
Leonean villages collected in 2009–2010, where 117 of 460
(25.4%) Mastomys were PCR-positive for an arenavirus (L. Moses
and D. Bausch, in prep.). We overlaid LASV prevalences in
rodents on the model predictions to assess whether explanatory
power existed at finer spatial scales. Because rodent sampling was
fairly restricted in its spatial extent, we related prevalence of LASV
in rodents to predicted suitability on the overall LF map (i.e., the
one in which all three biases described above had been corrected),
and evaluated the relationship between the two quantities using
linear regression.
Results
Effects of correcting for potential bias
Quality control. The original 107 case-occurrence points we
considered reduced to only 20 when only high-confidence points
(i.e., levels 1 and 2) were considered. Comparing models based on
these two data sets (Figure 3), models without occurrence data
quality control overemphasized humid areas of West and Central
Africa, at the expense of areas in the Sahel that may also be
suitable for LF occurrence. However, areas of contrast between
the two maps were spatially autocorrelated—that is, they were
highly contiguous, such that quality control of diagnoses of LF
cases had clear and consistent implications for the ecological niche
model that resulted and the potential distribution that was
reconstructed.
Reducing effects of oversampling. Of the original 111 LF
case-occurrence points considered by Fichet-Calvet and Rogers
[7], 44 came from southeastern Sierra Leone, southern Guinea,
and northwestern Liberia. To avoid over-representing of these
intensively sampled areas, we discarded 75% (33 occurrences)
based on occurrence point densities elsewhere (i.e., comparing
with Nigeria). As with the previous factor, this manipulation
caused clear, contiguous, and spatially autocorrelated macrogeo-
graphic effects that were more or less parallel to those in the
quality control manipulation (Figure 3). Again, humid areas of
West and Central Africa were overemphasized by models for
which sampling density was not controlled, while the Sahel was
underemphasized.
Balancing errors. Finally, we examined the effects of
balancing Type 1 and Type 2 error appropriately in niche model
development. This factor was examined based on the original set
of occurrence data, but with different consensus methods for
combining multiple replicate models in which all error was treated
equally versus when omission error rates were prioritized over
commission error rates. Overall, models with corrected (i.e., non-
equal) balance of error weightings identified a dramatically
broader area as suitable for LASV transmission, although the
original models did not emphasize any particular area overmuch
(Figure 3).
Three corrections to risk mapping procedures where individu-
ally assessed in the preceding paragraphs. The comparison
between the raw, unfixed, and corrected model outputs is quite
instructive. Raw model outputs resemble closely the maps
presented by Fichet-Calvet and Rogers [7] (see our Figures 2
and 4), emphasizing humid forest habitats across West Africa and
south and east into Central Africa. In contrast, the corrected
models extend considerably farther north into the more arid Sahel
region, but areas of Ghana and Côte d’Ivoire show more reduced
areas of suitability.
Sierra Leone: Effects of different random subsamplings
and model validation
Given that two of the three authors of this paper (LMM and
DGB) have considerable experience with LF in Sierra Leone, we
paid considerable attention to patterns of suitability that were
reconstructed in that region (Figure 5). The uneven pattern of
suitability in the region was intriguing, with areas of high and low
suitability reconstructed across the country. Hence, we took two
additional steps in exploring and understanding our models.
First, we repeated the random subsampling of 25% of the
occurrence data from that region 10 times, fitting new rangewide
models to see if our initial subsampling was in some way atypical
or nonrepresentative of a more general tendency. The replicate
analyses showed similar patterns of gaps among suitable areas
across the region, so we conclude that the fragmented suitable
areas shown in Figure 5 are a general pattern that is characteristic
of the broader data set and not a consequence of a particular
random subsampling.
Seeking an independent validation of predictions from our
models (see discussion in [25]), we were frustrated by the paucity
and uneven distribution of known occurrences of LF in Sierra
Leone. Although a rangewide independent data set for LF is not
available on which to base such a test, a smaller, more restricted
data set is available from testing rodents for LASV from work by
one of us (L. Moses, in prep.). Plotting LASV-infected rodent
prevalences against predicted suitability from the LF models (i.e.,
from the map in Figure 4) shows a positive relationship in which
high LASV prevalences are achieved at the highest modeled
suitability levels (Figure 5; R2 = 0.224, P,0.05). Hence, we see at
least a local-scale confirmation that patterns of variation in
modeled suitability have meaning for LASV prevalence in rodents.
Revised Transmission Risk Maps for Lassa Fever
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Discussion
This paper presents a series of insights into how disease
transmission can and should be reconstructed across space to
produce risk maps. Although we have focused on LF because of
the availability of the occurrence data and initial analyses from
Fichet-Calvet and Rogers [7], parallel analysis exist for the
distribution of other diseases, such as monkeypox [11]. We
emphasize that we in no way consider our results to be
comprehensive transmission risk maps; many details remain to
be addressed regarding the occurrence data (see below).
Caveats
It may be argued that our before-and-after comparisons are not
valid because we did not replicate the Fichet-Calvet and Rogers
analyses exactly. Indeed, we did not replicate their procedures in
two ways. First, Fichet-Calvet and Rogers took advantage of rich
environmental data sets developed by Scharlemann and colleagues
[26], in which multitemporal vegetation index data were processed
to produce a multidimensional picture of seasonality and
vegetation phenology. While we would very much have liked to
use this data set in our analyses, three separate requests to the
senior and corresponding authors were not answered.
Figure 3. Summary of effects of three factors assessed in this study as potentially influencing model outcomes: quality control of
input occurrence data (top panel), reduction of oversampling of occurrences in certain areas (middle), and weighting omission
versus commission errors appropriately (bottom). In each case, the map represents a difference between our corrected and our mimicking of
the original analysis such that a score of 100 (dark red) indicates a situation wherein the original analysis overemphasized the suitability of a site,
whereas a score of -100 (dark blue) indicates underemphasis. All three maps are shown on the same color scale.
doi:10.1371/journal.pone.0100711.g003
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Second, we did not use their same analytical approach, which
was a non-linear maximum likelihood discriminant analysis.
Instead, we purposefully used algorithms of known behavior
[27,28] that permitted us to assess more readily the error balance
question without major programming modifications [24]. With
regard to this latter point, our experience is that even very different
algorithms converge on similar solutions [9,10]. Because our
‘‘before’’ maps in our before-and-after comparisons (Figure 4)
closely resembled those of Fichet-Calvet and Rogers [7], we
believe that our manipulations were indeed effective and illustrate
the effects that are the point of this article.
The point
This set of analyses illustrates the importance of a rigorous
conceptual framework of ecology and biogeography that can take
into account the biases inherent in occurrence data for any
modeling and mapping exercises. Careful consideration of these
biases is essential in creating and interpreting distribution and risk
maps [9]. A firm conceptual framework that vets data thoroughly
and considers carefully how they should be incorporated into the
model guides one through a series of explicit assumptions that
place—to the greatest degree possible—analyses in the context of
an ecological niche on a biogeographic landscape [29].
This study illustrates the point that (1) lack of quality control of
occurrence data, (2) oversampling in clustered areas, and (3)
inappropriate equal weighting of error components in model
calibration all have macrogeographic implications for mapping
disease transmission risk. Each of these factors affects estimates of
risk and these effects are not randomly distributed spatially, but
rather have considerable spatial autocorrelation. This autocorre-
lation means that these factors actually make a macrogeographic
difference in the estimates that result, and that these factors must
be considered within a conceptual framework that takes them into
account integrally.
Indeed, if we combine the corrections to each of the three biases
into a final model and compare this to the uncorrected model, we
see serious geographic differences in reconstructed risk patterns
(Figure 4). The area predicted as suitable for LASV transmission
now appears considerably broader, and additional areas around
the Dahomey Gap and in the Sahel region that the original Fichet-
Calvet and Rogers maps did not include are appreciated as at risk.
The reasons behind these differences are clear from Figure 1; LF
occurrence points that we used to create our final models are more
evenly distributed across both humid and semiarid situations than
the original points used by Fichet-Calvet and Rogers, and the
extreme concentration in western-most Africa is largely removed.
As a result, the picture of environments suitable for LASV
Figure 4. Overall effect of the three corrections explored in this paper shown as the results of the ‘raw’ models designed to mimic
the original models [7] (top panel), models based on all three of the corrections together (middle), and the difference between the
two (bottom). In the bottom map, red areas are those overemphasized in the raw models, while blue areas indicate underemphasis of the raw
models.
doi:10.1371/journal.pone.0100711.g004
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transmission is broadened considerably. The error balance
manipulation serves to broaden this view still more. Indeed, in
2010, outbreaks of LF occurred in southern Mali and northwest-
ern Nigeria [30,31] (see also ProMed archive 20100519.1656),
areas depicted as low risk by Fichet-Calvet and Rogers, but as high
risk in our adjusted model outputs.
However, as mentioned above, even our corrected maps are far
from constituting final risk maps for LF. Many nuances and
additional elements would need to factored into a highly predictive
map, including: (1) Detailed maps of M. natalensis distribution.
LASV/LF occurrence data would ideally be derived from data on
LASV-infected rodents, rather than humans, for the aforemen-
tioned reasons related to the magnitude of movements of rodents
versus humans. However, understanding the distribution of M.
natalensis has been complicated by the existence of numerous
morphologically identical species and sub-species of Mastomys in
sub-Saharan Africa, often leading to misidentifications and
consequent errors in occurrence data. Fortunately, molecular
assays have recently been developed to allow reliable distinction
between Mastomys species [32]. (2) Consideration of additional
human behavioral and societal factors is crucial, as they may
modify risk by impacting probability of Mastomys occurrence and
LASV infection and/or transmission to humans (e.g., poverty and
socioeconomic status, levels of development, educational status,
land use, housing construction) and reporting (e.g., distance to
clinics and hospitals, medical personnel awareness of LF,
availability of diagnostic facilities, efficiency of reporting pipelines).
(3) Consideration of human genetic predisposition to LASV
infection and disease is important, as data now suggest that certain
genotypes in West African human populations may be protective
[33]. (4) Finally, and perhaps most importantly, maps would be
evaluated and tested rigorously via independent data sets, such
that confidence in ‘risk’ estimates can be taken into account
quantitatively. In this sense, the maps presented in this paper are
not risk maps, but rather explorations of factors that affect ability
to reconstruct disease transmission risk and to generate hypotheses
for further field testing, verification, and map refinement.
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10. Peterson AT, Papeş M, Eaton M (2007) Transferability and model evaluation in
ecological niche modeling: A comparison of GARP and Maxent. Ecography 30:
550–560.
11. Lash RR, Carroll DS, Hughes CM, Nakazawa Y, Karem K, et al. (2012) Effects
of georeferencing effort on mapping monkeypox case distributions and
transmission risk. International Journal of Health Geographics 11: 23.
12. Barve N, Barve V, Jiménez-Valverde A, Lira-Noriega A, Maher SP, et al. (2011)
The crucial role of the accessible area in ecological niche modeling and species
distribution modeling. Ecological Modelling 222: 1810–1819.
13. Bausch DG, Demby AH, Coulibaly M, Kanu J, Goba A, et al. (2001) Lassa fever
in Guinea: I. Epidemiology of human disease and clinical observations. Vector
Borne and Zoonotic Diseases 1: 269–281.
14. McCormick JB, King IJ, Webb PA, Johnson KM, O’Sullivan R, et al. (1987) A
case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis
155: 445–455.
15. Asogun DA, Adomeh DI, Ehimuan J, Odia I, Hass M, et al. (2012) Molecular
diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons
learnt from two years of laboratory operation. PLoS Negl Trop Dis 6: e1839.
16. Olschlager S, Gunther S (2012) Rapid and specific detection of Lassa virus by
reverse transcription-PCR coupled with oligonucleotide array hybridization.
J Clin Microbiol 50: 2496–2499.
17. Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, et al. (2000)
Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked
immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.
J Clin Microbiol 38: 2670–2677.
18. Van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC (1986)
Hemorrhagic fever virus infections in an isolated rainforest area of central
Liberia. Limitations of the indirect immunofluorescence slide test for antibody
screening in Africa. Trop Geogr Med 38: 209–214.
19. Waller L, Goodwin B, Wilson M, Ostfeld R, Marshall S, et al. (2007) Spatio-
temporal patterns in county-level incidence and reporting of Lyme disease in the
northeastern United States, 1990–2000. Environmental and Ecological Statistics
14: 83–100.
20. McCormick JB (1987) Epidemiology and control of Lassa fever. Curr Top
Microbiol Immunol 134: 69–78.
21. Panning M, Emmerich P, Olschlager S, Bojenko S, Koivogui L, et al. (2010)
Laboratory diagnosis of Lassa fever, Liberia. Emerg Infect Dis 16: 1041–1043.
22. Fielding AH, Bell JF (1997) A review of methods for the assessment of prediction
errors in conservation presence/absence models. Environmental Conservation
24: 38–49.
23. Stockwell DRB, Peters DP (1999) The GARP modelling system: Problems and
solutions to automated spatial prediction. International Journal of Geographical
Information Science 13: 143–158.
24. Anderson RP, Lew D, Peterson AT (2003) Evaluating predictive models of
species’ distributions: Criteria for selecting optimal models. Ecological Modelling
162: 211–232.
25. Peterson AT (2005) Kansas Gap Analysis: The importance of validating
distributional models before using them. Southwestern Naturalist 50: 230–236.
26. Scharlemann JPW, Benz D, Hay SI, Purse BV, Tatem AJ, et al. (2008) Global
data for ecology and epidemiology: A novel algorithm for temporal Fourier
processing MODIS data. PLoS ONE 3: e1408.
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